Purchase Order 75N95D20P00116

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on July 30, 2020, with an ultimate completion date of August 31, 2020. The order procures scientific equipment on a firm fixed price basis. Performance occurs at Nexcelom's facility in Lawrence, Massachusetts. No set-aside category was applied.</p>

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order to Nexcelom Bioscience LLC, a manufacturer of imaging cytometers, for the acquisition of a Celigo Imaging Cytometer. The $139,000.00 firm-fixed-price contract has an award date of September 5, 2018 and a completion date of October 3, 2018. The procurement was conducted on a sole source basis under FAR Part 13 without any set-aside designation....

This is a $12,180 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, to Nexcelom Bioscience LLC, a small business manufacturer and developer of image cytometry products for cell analysis in life science and biomedical research. The contract is for the provision of a Cellometer Auto 2000 cell counter, with a total small business set-aside. Nexcelom Bioscience LLC has previously...

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $24,732.00 on July 17, 2020, for scientific equipment. Performance occurs in Lawrence, Massachusetts. The order uses firm fixed price and carries no small business set-aside. Ultimate completion is August 15, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on September 14, 2020, for scientific equipment on a firm fixed price basis. Performance will occur in Lawrence, Massachusetts, with an ultimate completion date of November 11, 2020. No small business set-aside was applied.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Nexcelom Bioscience LLC for $60,630 on March 25, 2021, for one Cellaca MX high-speed cell counter equipped with fluorescence optical microscopy for automated image analysis, including brightfield imaging, fluorescence platform, and green and red optical channels. Work is performed in Lawrence, Massachusetts. The order is firm-fixed-price with an ultimate completion date of April 24, 2021. No small business...

This is a $24,980.00 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Nexcelom Bioscience LLC, a for-profit limited liability company that develops and markets image cytometry products for cell analysis. The contract is for the procurement of a Cellometer Vision cell counter, including shipping and handling, with a period of performance ending on October 6, 2013. This award...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases to Nexcelom Bioscience LLC, a for-profit limited liability company that manufactures imaging cytometry products for life science and biomedical research. The contract, valued at $120,000.00, is for the delivery of a CELIGO IMAGING CYTOMETER MODEL # 200-BFFL-4B. The contract has a completion date of...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Nexcelom Bioscience LLC for $119,000.00 on August 28, 2018. The order procures a Celigo Imaging Cytometer for cell analysis. Performance occurs in Lawrence, Massachusetts. The contract carries a firm fixed price and runs through November 30, 2018. The award originated from a special notice posted August 23, 2018.</p>

This is a $14,955.00 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency, to Nexcelom Bioscience LLC for a service contract to provide a cytometer. The contract has no set-aside designation and was awarded on June 28, 2020 with a completion date of June 27, 2021. Nexcelom Bioscience LLC is a for-profit limited liability company that develops and markets image cytometry products for cell analysis used in life science and biomedical research. Through prior...